Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Open-market sale Chief Medical Officer sold 28,002 shares at an average $60.09 ($1,682,554)
  2. 4 Open-market sale Chief Medical Officer sold 10,943 shares at an average $60.05 ($657,171)
  3. 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
  4. 4 Gift Director gave 3,415 shares (gift)
  5. 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
  9. 4 Exercise or conversion Director acquired 1,686 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Open-market sale Chief Commercial Officer sold 3,462 shares at $55.41 ($191,829)
  18. 4 Open-market sale Chief Medical Officer sold 17,611 shares at an average $55.12 ($970,636)
  19. 4 Open-market sale Principal Accounting Officer sold 1,118 shares at $55.89 ($62,485)
  20. 4 Open-market sale Principal Accounting Officer sold 991 shares at $54.00 ($53,514)

Page 14 of 38 · 758 filings